Autolus Therapeutics plc - American Depositary Shares (AUTL) by event type
AUTL moves most on analyst upgrades — a median of -2.15% at 30 minutes across 13 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the AUTL overview →
How AUTL reacts across 2 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,697 of 2,717 | 13 | -2.15% | 31% | -2.53% |
| Rating reiterations 988 of 3,522 | 58 | +0.07% | 52% | -1.12% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one. 4 further classes were observed with fewer than 10 measured events and are not published.
That’s how AUTL usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Rating reiterations → · AUTL overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | 377 | 0.00% | 49% |
| Amneal Pharmaceuticals, Inc. - Class A (AMRX) | 377 | -0.08% | 46% |
| Solid Biosciences Inc. (SLDB) | 375 | -0.17% | 46% |
| Halozyme Therapeutics, Inc. (HALO) | 374 | -0.11% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.